200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 254-60-4
CAS No: 254-60-4 Catalog No: AG0032NM MDL No:MFCD00059751
Title | Journal |
---|---|
Synthesis of a new series of pyridine and fused pyridine derivatives. | Molecules (Basel, Switzerland) 20120911 |
Methyl 1-ethyl-7-methyl-4-oxo-1,4-di-hydro-1,8-naphthyridine-3-carboxyl-ate monohydrate. | Acta crystallographica. Section E, Structure reports online 20120301 |
Enhancement of affinity in molecular recognition via hydrogen bonds by POSS-core dendrimer and its application for selective complex formation between guanosine triphosphate and 1,8-naphthyridine derivatives. | Organic & biomolecular chemistry 20120107 |
Selective G-quadruplex DNA stabilizing agents based on bisquinolinium and bispyridinium derivatives of 1,8-naphthyridine. | The Journal of organic chemistry 20120106 |
Towards crystal structure prediction of complex organic compounds--a report on the fifth blind test. | Acta crystallographica. Section B, Structural science 20111201 |
1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease. | Current topics in medicinal chemistry 20111101 |
7-Amino-1,8-naphthyridin-2(1H)-one monohydrate. | Acta crystallographica. Section E, Structure reports online 20110901 |
Hg2+ recognition by triptycene-derived heteracalixarenes: selectivity tuned by bridging heteroatoms and macrocyclic cavity. | Organic & biomolecular chemistry 20110821 |
2,6-Diamino-pyridinium tetra-phenyl-borate-1,2-bis-(5,7-dimethyl-1,8-naphthyridin-2-yl)diazene (1/1). | Acta crystallographica. Section E, Structure reports online 20110501 |
Palladium(II) complexes based on 1,8-naphthyridine functionalized N-heterocyclic carbenes (NHC) and their catalytic activity. | Dalton transactions (Cambridge, England : 2003) 20110114 |
A step further towards multitarget drugs for Alzheimer and neuronal vascular diseases: targeting the cholinergic system, amyloid-β aggregation and Ca(2+) dyshomeostasis. | Current medicinal chemistry 20110101 |
Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors. | International journal of molecular sciences 20110101 |
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. | Bioorganic & medicinal chemistry letters 20100801 |
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. | Journal of medicinal chemistry 20100722 |
Intense one- and two-photon excited fluorescent bis(BF2) core complex containing a 1,8-naphthyridine derivative. | Organic letters 20100702 |
2-Chloro-7-methyl-12-phenyldibenzo[b,g][1,8]naphthyridin-11(6H)-one. | Acta crystallographica. Section E, Structure reports online 20100701 |
Synthesis, characterization, photoinduced isomerization, and spectroscopic properties of vinyl-1,8-naphthyridine derivatives and their copper(I) complexes. | Inorganic chemistry 20100517 |
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. | Journal of medicinal chemistry 20100422 |
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists. | Journal of molecular modeling 20100401 |
[Molecular geometries and theoretical electronic spectra of four 1,8-naphthyridine derivatives]. | Guang pu xue yu guang pu fen xi = Guang pu 20100301 |
2,7-Bis-(trichloro-meth-yl)-1,8-naphthyridine. | Acta crystallographica. Section E, Structure reports online 20100301 |
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II. | PloS one 20100101 |
Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking. | International journal of molecular sciences 20100101 |
N'-[(E)-Benzyl-idene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide. | Acta crystallographica. Section E, Structure reports online 20091201 |
Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives. | Journal of enzyme inhibition and medicinal chemistry 20091001 |
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells. | The Journal of pharmacy and pharmacology 20090801 |
2,7-Dimethyl-1,8-naphthyridine. | Acta crystallographica. Section E, Structure reports online 20090801 |
Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines. | Bioorganic & medicinal chemistry 20090701 |
2,2',4,4'-Tetra-methyl-7,7'-diazenediylbis(1,8-naphthyridin-1-ium) bis-(perchlorate). | Acta crystallographica. Section E, Structure reports online 20090701 |
μ-Bis(5,7-dimethyl-1,8-naphthyridin-2-yl)diazene]bis-[difluoridoboron(III). | Acta crystallographica. Section E, Structure reports online 20090701 |
1-Ethyl-N'-[(E)-4-hydroxy-benzyl-idene]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide. | Acta crystallographica. Section E, Structure reports online 20090401 |
7-(2,2-Dimethylpropanamido)-2-methyl-1,8-naphthyridin-1-ium chloride monohydrate. | Acta crystallographica. Section E, Structure reports online 20090201 |
A 1,8-naphthyridine-based fluorescent chemodosimeter for the rapid detection of Zn2+ and Cu2+. | Organic letters 20081120 |
Synthesis of binuclear platinum complexes containing the ligands 8-naphthyridine, 2-aminopyridine, and 7-azaindolate. An experimental study of the steric hindrance of the bulky pentafluorophenyl ligands in the synthesis of binuclear complexes. | Inorganic chemistry 20081006 |
2,2'-Dimethyl-7,7'-(methyl-enediimino)di-1,8-naphthyridin-1-ium bis-(perchlorate). | Acta crystallographica. Section E, Structure reports online 20080901 |
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model. | Bioorganic & medicinal chemistry letters 20080601 |
Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyridine antagonists toward bovine adenosine receptors. | Journal of enzyme inhibition and medicinal chemistry 20080601 |
Naphthyridine-based helical foldamers and macrocycles: synthesis, cation binding, and supramolecular assemblies. | The Journal of organic chemistry 20080404 |
cis,trans-Dicarbonyl-dichlorido[2-(2-pyrid-yl)-1,8-naphthyridine-κN,N]ruthenium(II). | Acta crystallographica. Section E, Structure reports online 20080301 |
One-pot solvent free synthesis and DNA binding studies of thieno[2,3-b]-1,8-naphthyridines. | Preparative biochemistry & biotechnology 20080101 |
Effect of an alkyl amino group on the binding of 1,8-naphthyridines to AP site-containing DNA duplexes. | Nucleic acids symposium series (2004) 20080101 |
Dichloridobis(7-amino-2,4-dimethyl-1,8-naphthyridine-κN,N')cobalt(II) methanol disolvate. | Acta crystallographica. Section E, Structure reports online 20080101 |
Bis(7-amino-2,4-dimethyl-1,8-naphthyridine)dinitratocadmium(II). | Acta crystallographica. Section E, Structure reports online 20080101 |
7-Acetyl-amino-2,4-dimethyl-1,8-naphthyridine. | Acta crystallographica. Section E, Structure reports online 20080101 |
7-[4-(5,7-Dimethyl-1,8-naphthyridin-2-yl-oxy)phen-oxy]-2,4-dimethyl-1,8-naphthyridine methanol disolvate. | Acta crystallographica. Section E, Structure reports online 20080101 |
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. | Bioorganic & medicinal chemistry letters 20071201 |
Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. | Anti-cancer agents in medicinal chemistry 20071101 |
Photochromism of photoenolizable ketones in quinoline and 1,8-naphthyridine series studied by time-resolved absorption spectroscopy. | The journal of physical chemistry. A 20070315 |
Oxacalixarenes and oxacyclophanes containing 1,8-naphthyridines: a new class of molecular tweezers with concave-surface functionality. | Chemical communications (Cambridge, England) 20070314 |
Synthesis and spectral investigations of manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II) complexes of new polydentate ligands containing a 1,8-naphthyridine moiety. | Molecules (Basel, Switzerland) 20061221 |
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study. | Journal of inflammation (London, England) 20060101 |
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. | Bioorganic & medicinal chemistry letters 20051015 |
Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation. | Toxicology letters 20050704 |
Tetrakis(mu(2)-1,8-naphthyridine)-1:2kappa(4)N:N';3:4kappa(4)N:N'-bis(mu(2)-salicylato)-1:4kappa(2)O:O';2:3kappa(2)O:O'-tetrakis(salicylic acid)-1kappaO,2kappaO,3kappaO,4kappaO-tetrasilver(I)(4 Ag-Ag). | Acta crystallographica. Section C, Crystal structure communications 20050601 |
Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid. | Bioorganic & medicinal chemistry 20050215 |
Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents. | Bioorganic & medicinal chemistry letters 20040621 |
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants. | Bioorganic & medicinal chemistry letters 20040621 |
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives. | Journal of medicinal chemistry 20040603 |
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors. | Bioorganic & medicinal chemistry 20040415 |
Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2. | Journal of medicinal chemistry 20040408 |
Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. | Bioorganic & medicinal chemistry letters 20040322 |
Modeling the syn disposition of nitrogen donors at the active sites of carboxylate-bridged diiron enzymes. Enforcing dinuclearity and kinetic stability with a 1,2-diethynylbenzene-based ligand. | Inorganic chemistry 20031229 |
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists. | Bioorganic & medicinal chemistry 20031117 |
Synthesis of 3- or 4-phenyl-1,8-naphthyridine derivatives and evaluation of antimycobacterial and antimicrobial activity. | Farmaco (Societa chimica italiana : 1989) 20030901 |
Synthesis of variously substituted 1,8-naphthyridine derivatives and evaluation of their antimycobacterial activity. | Farmaco (Societa chimica italiana : 1989) 20020801 |
Synthesis and pharmacological activities of 1,8-naphthyridine derivatives. | Biological & pharmaceutical bulletin 20020601 |
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X. | European journal of medicinal chemistry 20010101 |
© 2019 Angene International Limited. All rights Reserved.